Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc�
15.27
-0.39 (-2.49%)
Jul 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.16 - 15.88
52 week 5.87 - 24.79
Open 15.87
Vol / Avg. 0.00/450,852.00
Mkt cap 571.13M
P/E     -
Div/yield     -
EPS -0.52
Shares 37.40M
Beta     -
Inst. own 94%
Jul 29, 2014
Q2 2014 ZELTIQ Aesthetics Inc Earnings Call - 4:30PM EDT - Add to calendar
Jul 29, 2014
Q2 2014 ZELTIQ Aesthetics Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 11, 2014
ZELTIQ Aesthetics Inc at Goldman Sachs Healthcare Conference
Jun 10, 2014
ZELTIQ Aesthetics Inc at William Blair & Company LLC Growth Stock Conference
Jun 2, 2014
ZELTIQ Aesthetics Inc at Jefferies Global Healthcare Conference (One-on-One Meeting)
May 30, 2014
ZELTIQ Aesthetics Inc Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -23.69% -17.29%
Operating margin -23.28% -17.33%
EBITD margin - -15.78%
Return on average assets -34.71% -21.65%
Return on average equity -49.86% -28.57%
Employees 297 -
CDP Score - -

Address

Suite 100, 4698 Willow Road
PLEASANTON, CA 94588
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zeltiq Aesthetics, Inc. operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. It develops Cryolipolysis, a technology that enables the reduction of fat tissue near nerves, muscle, and bones. The Company develops a non-invasive technology for aesthetic applications and plastic surgery. Its product is used as a skin cooling device to minimize pain and thermal injury during laser and dermatological treatments.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Patrick Williams Chief Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Keith Sullivan Senior Vice President of Worldwide Sales
Age: 56
Bio & Compensation  - Reuters
Len DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Director
Age: 52
Bio & Compensation  - Reuters
D. Keith Grossman Director
Age: 54
Bio & Compensation  - Reuters
Jean M. George Independent Director
Age: 56
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 58
Bio & Compensation  - Reuters